Bioventus Inc.
BVSNASDAQHealthcare● Active
$8.95
$-0.09(-1.00%)
Market Cap$606345030
P/E Ratio—
52W High$11.249
52W Low$5.81
Bioventus Inc. (BVS) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BVS · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.00B | ($0.00B) | ($0.12B) | ($0.14B) | $0.01B |
| Depreciation & Amort. | $0.00B | $0.05B | $0.06B | $0.06B | $0.03B |
| Stock-Based Comp. | $0.00B | $0.01B | $0.00B | $0.02B | $0.02B |
| Change in Working Capital | ($0.01B) | ($0.01B) | ($0.00B) | ($0.03B) | ($0.02B) |
| Net Cash from Operations | $0.07B | $0.04B | $0.02B | ($0.01B) | $0.02B |
| Investing Activities | |||||
| Capital Expenditure | ($0.00B) | ($0.00B) | ($0.01B) | ($0.00B) | ($0.02B) |
| Purchases of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Investing | ($0.00B) | $0.02B | $0.02B | ($0.12B) | ($0.28B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | ($0.00B) |
| Debt Issued / Repaid | ($0.04B) | ($0.06B) | ($0.02B) | $0.06B | $0.17B |
| Net Cash from Financing | ($0.06B) | ($0.05B) | ($0.03B) | $0.06B | $0.27B |
| Free Cash Flow | |||||
| Free Cash Flow | $0.07B | $0.04B | $0.01B | ($0.02B) | $0.00B |
| FCF Margin %(computed) | 12.57% | 6.59% | 1.56% | -2.93% | 0.49% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Bioventus Inc. data
About Bioventus Inc. (BVS) Cash Flow Statement
Bioventus Inc. generated operating cash flow of $0.07B and free cash flow of $0.07B for 2025 — a FCF margin of 12.57%. Capital expenditure was ($0.00B).
Frequently asked questions
BVS · 4 questionsBioventus Inc. generated free cash flow of $0.07B for 2025, up 89.0% year-over-year.
BVS free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10